Chaoxun Wang
Pudong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Hemodynamic effects of finerenone on blood pressure and heart rate in hospitalized patients with type 2 diabetes: a real-world study.
Journal: Frontiers in endocrinology
Published: May 11, 2026
Cardiovascular outcome trials (CVOTs) in cardiorenal metabolic medicine: a decade of transformative progress (2016-2026).
Journal: Cardiovascular diabetology
Published: January 21, 2026
The Renal Micro-Vasculopathy and Systemic Aldosterone-Renin Ratio (ARR) in Type 2 Diabetic Patients-A Retrospective Real-World Study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: August 26, 2025
The effects of non-insulin anti-diabetic medications on the diabetic microvascular complications: a systematic review and meta-analysis of randomized clinical trials.
Journal: BMC endocrine disorders
Published: April 07, 2025
The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: January 16, 2025
Temporal response patterns of human gut microbiota to dietary fiber.
Journal: iMeta
Published: December 23, 2024
Relationship Between Sporadic Renal Cysts and Renal Function Detected by Isotope Renography in Type 2 Diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 02, 2022
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is).
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 24, 2021
Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 05, 2021
Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: April 28, 2020
The Mechanism of Metabolic Influences on the Endogenous GLP-1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus.
Journal: Journal of diabetes research
Published: March 12, 2020
Last Updated: 09/26/2026